TTY BIOPHARM monthly revenue
TTY BIOPHARM LTD
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.6B | +19.1% | +15.3% | NT$3.2B |
| May 2026 | Jun 17, 2026 | NT$0.5B | +0.0% | -3.6% | NT$2.6B |
| Apr 2026 | May 17, 2026 | NT$0.5B | -13.6% | +17.9% | NT$2B |
| Mar 2026 | Apr 17, 2026 | NT$0.6B | +66.8% | +5.8% | NT$1.5B |
| Feb 2026 | Mar 17, 2026 | NT$0.4B | -35.9% | -12.1% | NT$0.9B |
| Jan 2026 | — | NT$0.6B | — | +16.2% | NT$0.6B |
| Dec 2025 | — | NT$0.6B | — | +3.1% | NT$6.5B |
| Nov 2025 | — | NT$0.5B | — | +7.0% | NT$5.8B |
| Oct 2025 | — | NT$0.5B | — | -16.0% | NT$5.3B |
| Sep 2025 | — | NT$0.9B | — | +45.1% | NT$4.8B |
| Aug 2025 | — | NT$0.5B | — | +3.2% | NT$3.9B |
| Jul 2025 | — | NT$0.5B | — | -0.2% | NT$3.5B |
| Jun 2025 | — | NT$0.5B | — | +13.0% | NT$3B |
| May 2025 | — | NT$0.5B | — | +21.1% | NT$2.4B |
| Apr 2025 | — | NT$0.4B | — | -3.8% | NT$1.9B |
| Mar 2025 | — | NT$0.6B | — | +42.6% | NT$1.5B |
| Feb 2025 | — | NT$0.4B | — | +49.0% | NT$0.9B |
| Jan 2025 | — | NT$0.5B | — | -19.7% | NT$0.5B |
| Dec 2024 | — | NT$0.6B | — | +20.8% | NT$5.9B |
| Nov 2024 | — | NT$0.5B | — | -6.5% | NT$5.3B |
| Oct 2024 | — | NT$0.6B | — | -2.2% | NT$4.8B |
| Sep 2024 | — | NT$0.6B | — | +3.4% | NT$4.2B |
| Aug 2024 | — | NT$0.4B | — | +4.7% | NT$3.6B |
| Jul 2024 | — | NT$0.5B | — | +14.3% | NT$3.1B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.